Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability
- 12 April 2008
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 57 (12) , 1879-1890
- https://doi.org/10.1007/s00262-008-0518-1
Abstract
Theoretical analyses suggest that the cellular internalization and catabolism of bound antibodies contribute significantly to poor penetration into tumors. Here we quantitatively assess the internalization of antibodies and antibody fragments against the commonly targeted antigen carcinoembryonic antigen (CEA). Although CEA is often referred to as a non-internalizing or shed antigen, anti-CEA antibodies and antibody fragments are shown to be slowly endocytosed by LS174T cells with a half-time of 10–16 h, a time scale consistent with the metabolic turnover rate of CEA in the absence of antibody. Anti-CEA single chain variable fragments (scFvs) with significant differences in affinity, stability against protease digestion, and valency exhibit similar uptake rates of bound antibody. In contrast, one anti-CEA IgG exhibits unique binding and trafficking properties with twice as many molecules bound per cell at saturation and significantly faster cellular internalization after binding. The internalization rates measured herein can be used in simple computational models to predict the microdistribution of these antibodies in tumor spheroids.Keywords
This publication has 42 references indexed in Scilit:
- Quantitative Spatiotemporal Analysis of Antibody Fragment Diffusion and Endocytic Consumption in Tumor SpheroidsCancer Research, 2008
- A33 antigen displays persistent surface expressionCancer Immunology, Immunotherapy, 2008
- Theoretic Criteria for Antibody Penetration into Solid Tumors and MicrometastasesJournal of Nuclear Medicine, 2007
- Comparative uptakes and biodistributions of internalizing vs. noninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancerNuclear Medicine and Biology, 2005
- Integrating cell-level kinetic modeling into the design of engineered protein therapeuticsNature Biotechnology, 2005
- Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 CProtein Engineering, Design and Selection, 2004
- Reversible Dimer Formation and Stability of the Anti-tumour Single-chain Fv Antibody MFE-23 by Neutron Scattering, Analytical Ultracentrifugation, and NMR and FT-IR SpectroscopyJournal of Molecular Biology, 2002
- Computational Model for Effects of Ligand/Receptor Binding Properties on Interleukin-2 Trafficking Dynamics and T Cell Proliferation ResponseBiotechnology Progress, 2000
- The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissuesSeminars in Cancer Biology, 1999
- Carcinoembryonic Antigen as a Target for Radioimmunotherapy of Human Medullary Thyroid Carcinoma: Antibody Processing, Targeting, and Experimental Therapy with 131I and 90Y Labeled MAbsCancer Biotherapy & Radiopharmaceuticals, 1999